Clinical Research Directory
Browse clinical research sites, groups, and studies.
Trial of the F2 Filter and Delivery System for Embolic Protection During TAVR
Sponsor: EnCompass Technologies, Inc.
Summary
The objective of this study is to compare the safety and effectiveness of the F2 Cerebral Protection System (CPS) to a standard of care control group in patients undergoing Transcatheter Aortic Valve Replacement (TF TAVR)
Official title: A Prospective, Randomized, Multicenter, Single-blind Trial to Assess the Safety and Effectiveness of the Encompass F2 Cerebral Protection System Vs. Standard of Care (Unprotected or Sentinel® Cerebral Protection System) During Transfemoral Transcatheter Aortic Valve Replacement
Key Details
Gender
All
Age Range
50 Years - Any
Study Type
INTERVENTIONAL
Enrollment
500
Start Date
2025-09-09
Completion Date
2027-01
Last Updated
2025-11-20
Healthy Volunteers
No
Interventions
F2 Filter and Delivery System
Use of the F2 Filter and Delivery System in conjunction with a Transcatheter Aortic Valve Replacement (TAVR) procedure
Transcatheter Aortic Valve Replacement (TAVR)
Transcatheter Aortic Valve Replacement (TAVR) with commercially available Transcatheter Aortic Valve Replacement (TAVR) device
Locations (10)
NCH Baker Hospital-Naples Heart Institute
Naples, Florida, United States
St. Vincent Hospital
Indianappolis, Indiana, United States
Henry Ford Hospital
Detroit, Michigan, United States
St. Lukes Hospital Of Kansas City
Kansas City, Missouri, United States
Cumc/Nyph
New York, New York, United States
Cleveland Clinic Foundation
Cleveland, Ohio, United States
Ohio Health Research Institute (aka Riverside Methodist Hospital)
Columbus, Ohio, United States
University of Virginia Medical Center
Charlottesville, Virginia, United States
St Andrews War Memorial Hospital
Spring Hill, Queensland, Australia
Monash Health Public
Clayton, Victoria, Australia